Frequency of in-Stent Restenosis in patients having DES, with Stent Length Greater than 30mm Presenting to Tertiary Care Center

Objective: The purpose of this study was to calculate the incidence in-stent restenosis in patients with DES and stent lengths higher than 30mm who presented a tertiary care hospital. Study Design: A Cross-sectional Place Duration: This cross-sectional conducted at Department Cardiology, Rashid Latif Medical College, Lahore duration from February, 2022 July, 2022. Methods: There were 83 coronary artery disease (CAD)were included. After obtaining written consent participants, researchers collected information about their participants' ages, sexes, body mass indexes, co-morbidities. Atherosclerosis risk variables baseline investigations an echocardiography for ejection fraction determination. Imaging studies reviewed by board-certified interventional cardiologists, found evidence ISR. Past angioplasty details recorded. Results: In our mean age cases 54.13±7.44 years BMI 25.2±13.87 kg/m2. Most common comorbidity diabetes 25 (30.1%) followed hypertension 23 (27.7%) dyslipidemia 20 (24.1%) cases. We that 40 (48.2%) smokers. Mean LDL cholesterol 68.6±1.97 mg/dl uric acid 6.2±2.35 mg/dl. Majority 45 (54.2%) had poor socio-economic status. frequency ISR among biomatrix 24 (28.9%), Xience 22 (26.5%) cases, Ultimaster 19 (22.9%) Xlimus 18 (21.7%) after angiograpghy. Our results showed stents longer associated In-Stent Restenosis (p=0.03). Conclusion: Based on findings study, we came conclusion previous diagnosis mellitus length are both significant factors developing restenosis. research, instances greater Keywords: CAD, Drug eluting (DES), Coronary angiography,